Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Gravid Treatment Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Gravid Treatment Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Topical Products
      • 1.3.3 Lasers
      • 1.3.4 Microdermabrasion
      • 1.3.5 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Gravid Treatment Market Share by Application (2019-2025)
      • 1.4.2 Hospitals
      • 1.4.3 Clinics
      • 1.4.4 Specialty Dermatology Centers
      • 1.4.5 Home-use
      • 1.4.6 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Gravid Treatment Production Value 2014-2025
      • 2.1.2 Global Gravid Treatment Production 2014-2025
      • 2.1.3 Global Gravid Treatment Capacity 2014-2025
      • 2.1.4 Global Gravid Treatment Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Gravid Treatment Market Size CAGR of Key Regions
      • 2.2.2 Global Gravid Treatment Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Gravid Treatment Capacity by Manufacturers
      • 3.1.2 Global Gravid Treatment Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Gravid Treatment Revenue by Manufacturers (2014-2019)
      • 3.2.2 Gravid Treatment Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Gravid Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.3 Gravid Treatment Price by Manufacturers
    • 3.4 Key Manufacturers Gravid Treatment Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Gravid Treatment Market
    • 3.6 Key Manufacturers Gravid Treatment Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Topical Products Production and Production Value (2014-2019)
      • 4.1.2 Lasers Production and Production Value (2014-2019)
      • 4.1.3 Microdermabrasion Production and Production Value (2014-2019)
      • 4.1.4 Others Production and Production Value (2014-2019)
    • 4.2 Global Gravid Treatment Production Market Share by Type
    • 4.3 Global Gravid Treatment Production Value Market Share by Type
    • 4.4 Gravid Treatment Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Gravid Treatment Consumption by Application

    6 Production by Regions

    • 6.1 Global Gravid Treatment Production (History Data) by Regions 2014-2019
    • 6.2 Global Gravid Treatment Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Gravid Treatment Production Growth Rate 2014-2019
      • 6.3.2 United States Gravid Treatment Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Gravid Treatment Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Gravid Treatment Production Growth Rate 2014-2019
      • 6.4.2 European Union Gravid Treatment Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Gravid Treatment Import & Export
    • 6.5 China
      • 6.5.1 China Gravid Treatment Production Growth Rate 2014-2019
      • 6.5.2 China Gravid Treatment Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Gravid Treatment Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Gravid Treatment Consumption by Regions

    • 7.1 Global Gravid Treatment Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Gravid Treatment Consumption by Type
      • 7.2.2 United States Gravid Treatment Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Gravid Treatment Consumption by Type
      • 7.3.2 European Union Gravid Treatment Consumption by Application
    • 7.4 China
      • 7.4.1 China Gravid Treatment Consumption by Type
      • 7.4.2 China Gravid Treatment Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Gravid Treatment Consumption by Type
      • 7.5.2 Rest of World Gravid Treatment Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Laboratoires Expanscience
      • 8.1.1 Laboratoires Expanscience Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Gravid Treatment
      • 8.1.4 Gravid Treatment Product Introduction
      • 8.1.5 Laboratoires Expanscience Recent Development
    • 8.2 Clarins Group
      • 8.2.1 Clarins Group Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Gravid Treatment
      • 8.2.4 Gravid Treatment Product Introduction
      • 8.2.5 Clarins Group Recent Development
    • 8.3 Merz North America, Inc. (Merz Group)
      • 8.3.1 Merz North America, Inc. (Merz Group) Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Gravid Treatment
      • 8.3.4 Gravid Treatment Product Introduction
      • 8.3.5 Merz North America, Inc. (Merz Group) Recent Development
    • 8.4 E.T. Browne Drug
      • 8.4.1 E.T. Browne Drug Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Gravid Treatment
      • 8.4.4 Gravid Treatment Product Introduction
      • 8.4.5 E.T. Browne Drug Recent Development
    • 8.5 Cynosure
      • 8.5.1 Cynosure Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Gravid Treatment
      • 8.5.4 Gravid Treatment Product Introduction
      • 8.5.5 Cynosure Recent Development
    • 8.6 Syneron Medical Ltd.
      • 8.6.1 Syneron Medical Ltd. Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Gravid Treatment
      • 8.6.4 Gravid Treatment Product Introduction
      • 8.6.5 Syneron Medical Ltd. Recent Development
    • 8.7 Union-Swiss (Pty) Ltd.
      • 8.7.1 Union-Swiss (Pty) Ltd. Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Gravid Treatment
      • 8.7.4 Gravid Treatment Product Introduction
      • 8.7.5 Union-Swiss (Pty) Ltd. Recent Development
    • 8.8 Basq Skincare
      • 8.8.1 Basq Skincare Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Gravid Treatment
      • 8.8.4 Gravid Treatment Product Introduction
      • 8.8.5 Basq Skincare Recent Development
    • 8.9 Ellipse A/S
      • 8.9.1 Ellipse A/S Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Gravid Treatment
      • 8.9.4 Gravid Treatment Product Introduction
      • 8.9.5 Ellipse A/S Recent Development
    • 8.10 The Boppy Company
      • 8.10.1 The Boppy Company Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Gravid Treatment
      • 8.10.4 Gravid Treatment Product Introduction
      • 8.10.5 The Boppy Company Recent Development
    • 8.11 Helix BioMedix
    • 8.12 Weleda AG
    • 8.13 Dermaclara
    • 8.14 Mama Mio US
    • 8.15 Centre Light Solutions

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Gravid Treatment Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Gravid Treatment Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Gravid Treatment Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Gravid Treatment Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Gravid Treatment Production Forecast by Type
      • 9.7.2 Global Gravid Treatment Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Gravid Treatment Sales Channels
      • 10.2.2 Gravid Treatment Distributors
    • 10.3 Gravid Treatment Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      In 2019, the market size of Gravid Treatment is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Gravid Treatment.

      This report studies the global market size of Gravid Treatment, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Gravid Treatment production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Laboratoires Expanscience
      Clarins Group
      Merz North America, Inc. (Merz Group)
      E.T. Browne Drug
      Cynosure
      Syneron Medical Ltd.
      Union-Swiss (Pty) Ltd.
      Basq Skincare
      Ellipse A/S
      The Boppy Company
      Helix BioMedix
      Weleda AG
      Dermaclara
      Mama Mio US
      Centre Light Solutions

      Market Segment by Product Type
      Topical Products
      Lasers
      Microdermabrasion
      Others

      Market Segment by Application
      Hospitals
      Clinics
      Specialty Dermatology Centers
      Home-use
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Gravid Treatment status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Gravid Treatment manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Gravid Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now